Table 3 Annual percentage change of world age-standardized incidence rate by topographic groups, histologic types. FRANCIM network data 2000–2013 (11 registries)

 Soft Tissue

0.8

(−0.4; 2.0)

 Bone

1.2

(−0.4; 2.9)

 Skin

-2.0^a

(−3.5; −0.4)

  Gastro-intestinal organs

1.5

(−0.3; 3.3)

  Female genital organs

4.2

(−4.2; 13.2)

−6.7^a

(−10.4; −2.7)

  Other visceral organs

−1.7

(−5.1; 1.8)

  Other anatomic sites

1.0

(−3.4; 5.6)

 Unclassified sarcoma

−1.6

(−3.6; 0.3)

 Leiomyosarcoma

−2.6^a

(−4.6; −0.6)

 GIST

3.7^a

(0.8; 6.8)

 Liposarcoma

1.3

(−1.1; 3.7)

 Dermatofibrosarcoma

0.6

(−1.4; 2.7)

 Chondrosarcoma

4.1^a

(1.6; 6.6)

 Kaposi sarcoma

−4.1^a

(−6.8; −1.4)

 Osteosarcoma

−0.6

(−3.7; 2.6)

 Angiosarcoma

2.2

(−1.2; 5.7)

 Ewing sarcoma

−0.2

(−4.1; 3.8)

 Rhabdomyosarcoma

−1.1

(−6.2; 4.4)

 Others (with fewer than 20 cases)

4.1

(−1.3; 9.8)

 Synovial sarcoma

1.2

(−4.2; 6.9)

 Nerve Sheath Tumors

−0.1

(−4.3; 4.4)

 Myxofibrosarcoma

8.2^a

(0.4; 16.6)

 Endometrial stromal sarcoma

−3.7

(−7.4; 0.1)

 Fibrosarcoma

−9.2^a

(−15.7; −2.3)

 Chordoma

0.8

(−4.8; 6.6)

 Solitary fibrous tumor. Malignant

12.2^a

(6.2; 18.5)

 Epithelioid haemangioendothelioma

–

–

 Myoepithelial carcinoma

–

–

Total

3.6^a

(0.2; 7.1)

−1.4

(−2.9; 0.1)